LYMPHOMA, HODGKIN

Clinical trials for LYMPHOMA, HODGKIN explained in plain language.

Never miss a new study

Get alerted when new LYMPHOMA, HODGKIN trials appear

Sign up with your email to follow new studies for LYMPHOMA, HODGKIN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1 Completed 2

Could a custom chemo dose make stem cell transplants safer?

Disease control Ongoing

This early-phase study tests a new way to calculate the dose of the chemotherapy drug melphalan for lymphoma patients about to receive a stem cell transplant. Instead of a fixed dose based on height and weight, researchers use a model that considers how previous patients processe…

Matched conditions: LYMPHOMA, HODGKIN

Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control

Last updated Jun 27, 2026 09:10 UTC

LYMPHOMA, HODGKIN

Get alerted when new LYMPHOMA, HODGKIN trials appear

Could a custom chemo dose make stem cell transplants safer?